Gastric Cancer

, Volume 12, Issue 2, pp 88–94 | Cite as

A clinicopathological study of gastric stump carcinoma following proximal gastrectomy

  • Shigekazu Ohyama
  • Masanori Tokunaga
  • Naoki Hiki
  • Tetsu Fukunaga
  • Junko Fujisaki
  • Yasuyuki Seto
  • Toshiharu Yamaguchi
Original Article



We aimed to clarify the frequency and clinicopathological characteristics of gastric stump carcinoma following proximal gastrectomy.


Three-hundred and sixteen patients who had undergone curative proximal gastrectomy over a 21-year period from January 1984 through December 2004 were reviewed.


Gastric stump carcinoma was observed in 17 patients (5.4%). The time interval between the initial gastrectomy and the treatment of gastric stump cancer was within 5 years in 3 patients, within 5–10 years in 8, and after 10 years in 6. Treatment included endoscopic resection (n = 4), completion total gastrectomy of the remnant stomach (n = 11), pancreatoduodenectomy (n = 1), and nonsurgical resection (n = 1). Pathologically, 9 carcinomas were differentiated and 8 were undifferentiated. In a review of reconstruction methods associated with disease stage, stage I was found in 6 of the 7 patients with esophagogastrostomy or short-segment jejunal interposition. On the other hand, stage I was found in only 3, but stage II–IV was found in 7 of the 10 patients with reconstruction by double-tract or long-segment jejunal interposition; thus, the tumor was more likely to be detected at an advanced stage after long-segment interposition (P = 0.049).


Gastric stump carcinoma following proximal gastrectomy occurred at a high frequency of 5.4% of initial resections. It is necessary to select a reconstruction method that facilitates postoperative endoscopic examination, as well as to follow up the patients after proximal gastrectomy in the long term for the early detection and early treatment of gastric stump carcinoma.

Key words

Gastric stump carcinoma Proximal gastrectomy Jejunal interposition 


  1. 1.
    Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123:127–130.PubMedGoogle Scholar
  2. 2.
    Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 2003;90:850–853.PubMedCrossRefGoogle Scholar
  3. 3.
    Iwata T, Kurita N, Ikemoto T, Nishioka M, Andoh T, Shimada M. Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology 2006;53:301–303.PubMedGoogle Scholar
  4. 4.
    Takeshita K, Saito N, Saeki I, Honda T, Tani M, Kando F, et al. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: surgical techniques and evaluation of postoperative function. Surgery 1997;121:278–286.PubMedCrossRefGoogle Scholar
  5. 5.
    Hoshikawa T, Denno R, Ura H, Yamaguchi K, Hirata K. Proximal gastrectomy and jejunal pouch interposition: evaluation of postoperative symptoms and gastrointestinal hormone secretion. Oncol Rep 2001;8:1293–1299.PubMedGoogle Scholar
  6. 6.
    Nozaki I, Kurita A, Nasu J, Kubo Y, Aogi K, Tanada M, et al. Higher incidence of gastric remnant cancer after proximal than distal gastrectomy. Hepatogastroenterology 2007;54:1604–1608.PubMedGoogle Scholar
  7. 7.
    Kaminishi N, Shimizu N, Hiki N, Nomura Y, Nozaki K, Imamura K, et al. Clinicopathological features of gastric remnant cancer after corpofundectomy for gastric cancer (In Japanese). Stomach and Intestine 2004;39:1049–1057.Google Scholar
  8. 8.
    Igami G, Isotani M, Harada T, Kaneoka Y, Akutagawa A, Sugawara G, et al. Remnant stomach cancer after proximal gastrectomy: a review of 26 cases in the Japanese literature. Jpn J Gastroenterol Surg 2002;35:357–361.Google Scholar
  9. 9.
    Newman E, Brennan MF, Hochwald SN, Harrison LE, Karpeh MS Jr. Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity? Am J Surg 1997;173:292–297.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaneko K, Kondo H, Saito D, Shirao K, Yamaguchi H, Yokota T, et al. Early gastric stump cancer following distal gastrectomy. Gut 1998;43:342–344.PubMedCrossRefGoogle Scholar
  11. 11.
    Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 2005;92:235–239.PubMedCrossRefGoogle Scholar
  12. 12.
    Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma — epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol 2007;33:133–139.PubMedCrossRefGoogle Scholar
  13. 13.
    Ishikawa M, Kitayama J, Kaizaki S, Nakayama H, Ishigami H, Fujii S, et al. Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg 2005;29:1415–1420; discussion 1421.PubMedCrossRefGoogle Scholar
  14. 14.
    Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 2007;94:92–95.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaminishi M, Shimizu N, Shiomoyama S, Yamaguchi H, Ogawa T, Sakai S, et al. Etiology of gastric remnant cancer with special reference to the effects of denervation of the gastric mucosa. Cancer 1995;75:1490–1496.PubMedCrossRefGoogle Scholar
  16. 16.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma — 2nd English edition —. Gastric Cancer 1998;1:10–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Tokudome S, Kono S, Ikeda M, Kuratsune M, Sano C, Inokuchi K, et al. A prospective study on primary gastric stump cancer following partial gastrectomy for benign gastroduodenal diseases. Cancer Res 1984;44:2208–2212.PubMedGoogle Scholar
  18. 18.
    Asano A, Mizuno S, Sasaki R, Aoki K, Yokoyama H, Yokoyama Y. The long-term prognosis of patients gastrectomized for benign gastroduodenal diseases. Jpn J Cancer Res 1987;78:337–348.PubMedGoogle Scholar
  19. 19.
    Inokuchi K, Tokudome S, Ikeda M, Kuratsune M, Ichimiya H, Kaibara N, et al. Mortality from carcinoma after partial gastrectomy. Gann 1984;75:588–594.PubMedGoogle Scholar
  20. 20.
    Viste A, Bjornestad E, Opheim P, Skarstein A, Thunold J, Hartveit F, et al. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet 1986;2:502–505.PubMedCrossRefGoogle Scholar
  21. 21.
    Fisher SG, Davis F, Nelson R, Weber L, Goldberg J, Haenszel W. A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst 1993;85:1303–1310.PubMedCrossRefGoogle Scholar
  22. 22.
    Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg 1989;210:159–164.PubMedCrossRefGoogle Scholar
  23. 23.
    Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 1988;319:195–200.PubMedGoogle Scholar
  24. 24.
    Miwa K, Hattori T, Miyazaki I. Duodenogastric reflux and foregut carcinogenesis. Cancer 1995;75:1426–1432.PubMedCrossRefGoogle Scholar
  25. 25.
    Kondo K, Kojima H, Akiyama S, Ito K, Takagi H. Pathogenesis of adenocarcinoma induced by gastrojejunostomy in Wistar rats: role of duodenogastric reflux. Carcinogenesis 1995;16:1747–1751.PubMedCrossRefGoogle Scholar
  26. 26.
    Byrne JP, Attwood SE. Duodenogastric reflux and cancer. Hepatogastroenterology 1999;46:74–85.PubMedGoogle Scholar
  27. 27.
    Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinborn M, et al. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997;112:280–286.PubMedCrossRefGoogle Scholar
  28. 28.
    Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36–47.PubMedCrossRefGoogle Scholar
  29. 29.
    Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, et al. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997;113:1015–1025.PubMedCrossRefGoogle Scholar
  30. 30.
    Wright NA. Trefoil peptides and the gut. Gut 1993;34:577–579.PubMedCrossRefGoogle Scholar
  31. 31.
    Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002;62:233–240.PubMedGoogle Scholar
  32. 32.
    Taupin D, Pedersen J, Familari M, Cook G, Yeomans N, Giraud AS. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 2001;81:397–408.PubMedGoogle Scholar
  33. 33.
    Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Kikuchi S, Nemoto Y, Katada N, Sakuramoto S, Kobayashi N, Shimao H, et al. Results of follow-up endoscopy in patients who underwent proximal gastrectomy with jejunal interposition for gastric cancer. Hepatogastroenterology 2007;54:304–307.PubMedGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2009

Authors and Affiliations

  • Shigekazu Ohyama
    • 1
  • Masanori Tokunaga
    • 1
  • Naoki Hiki
    • 1
  • Tetsu Fukunaga
    • 1
  • Junko Fujisaki
    • 2
  • Yasuyuki Seto
    • 3
  • Toshiharu Yamaguchi
    • 1
  1. 1.Department of SurgeryCancer Institute Hospital of JFCRTokyoJapan
  2. 2.Department of Internal MedicineCancer Institute Hospital of JFCRTokyoJapan
  3. 3.Department of Gastrointestinal SurgeryThe University of Tokyo, Graduate School of MedicineTokyoJapan

Personalised recommendations